Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 1Cognitive Dysfunction 1Brain Neoplasms 1

Interventions

Patient Reported Outcome Measures 2Neuropsychological Tests 2lithium sulfate 1XENP 1595 1Tablets 1Sodium Chloride 1Ramipril 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Quality of Life 1Pioglitazone 1Metformin 1Mental Status and Dementia Tests 1Memantine 1Lithium 1G(M1) Ganglioside 1Donepezil 1Climate Anxiety 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Ramipril × CNS × Clear all
NCT03475186 2026-03-13

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Wake Forest University Health Sciences

Phase 2 Completed
75 enrolled 47 charts
CNS

Brain Neoplasms, Glioblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡